Nitrogen Dioxide Toxicity Workup
- Author: Nader Kamangar, MD, FACP, FCCP, FCCM; Chief Editor: Ryland P Byrd, Jr, MD more...
No laboratory studies that are specific to the diagnosis of nitrogen dioxide (NO2)–induced illness have been reported. However, in addition to a thorough history, the following blood studies can be helpful in excluding other causes of the symptoms and should be ordered based on clinical suspicion or history:
To assess severity of disease, request the following:
- Arterial blood gas (ABG) or venous blood gas (VBG) levels
- Lactate level
- Methemoglobin (MHb) level
To help rule out infectious etiologies, request the following:
- Sputum culture and Gram stain
- Respiratory virus polymerase chain reaction (PCR) panel
- Urine Legionella
- Coccidioides immunoglobulin G and immunoglobulin M
- Histoplasma enzyme immunoassay
- Cryptococcal antigen
Other tests to possibly consider include the following:
- Glucose levels
- Complete blood cell (CBC) count
Significant nitrogen dioxide (NO2) exposure usually results in hypoxemia. Initial blood gas levels establish the presence and severity of gas exchange impairment, and are extremely important in deciding whether to intubate. Some literature supports obtaining serial ABG levels during follow-up visits to ascertain whether bronchiolitis obliterans is developing. Metabolic acidosis can occur by dissolution of nitrous oxide in body fluids, resulting in tissue hypoxemia and subsequent lactic acid formation.
Measure MHb to evaluate cyanosis that does not respond to oxygen administration. MHb is an inactive oxidized form of hemoglobin that does not contribute to oxygen transport; levels greater than 10-15% result in cyanosis. MHb levels may be increased after exposure to NO2. Although levels as high as 71% have been reported following exposure to nitrous fumes, welders exposed to NO2 at 4-5 ppm (4000-5000 ppb) were noted to have MHb levels of 2-3%. Methylene blue administration can affect this test result.
On the CBC count, leukocytosis is often present in patients who have been exposed to NO2. Peripheral eosinophilia may suggest an alternative cause of pulmonary inflammation more consistent with allergic or reactive airway disease.
Measure glucose levels to assure that anxiety and restlessness is not caused by concomitant hypoglycemia. Exposure to NO2 does not cause a primary hypoglycemia.
Findings may be normal. During acute injury, the chest radiograph shows ill-defined, alveolar opacities, which are characteristic of pulmonary edema or acute respiratory distress syndrome (ARDS). Subacute injury reveals patchy, bilateral confluent woolly air-opacities. The small opacities can be mistaken for miliary tuberculosis. See the images below.
High resolution CT presentations vary from patchy subpleural ground glass opacities to a diffuse hyperlucency.
Pulmonary Function Testing
Pulmonary function tests (PFTs) should be performed as soon as possible to establish the extent of involvement. Repeat PFTs may be performed at regular intervals to chart progress and recovery. PFTs obtained late in the clinical course when bronchiolitis obliterans has developed may demonstrate presence of obstructive disease with prolonged forced expiratory volume at 1 second (FEV1).
Proliferative bronchiolitis is characterized by granulation tissue that primarily involves the bronchiolar lumen. It rarely involves alveolar spaces. In contrast constrictive bronchiolitis involves collagenous scarring of the lumen with proliferation of underlying smooth muscle and occasional luminal erosions.
In patients who die quickly from nitrogen dioxide (NO2) toxicity, microscopic evaluation of lung tissue shows hemorrhagic edema and extensive damage of the respiratory epithelium. Complete shedding of the epithelium may occur in the small bronchi and bronchioles.
In patients who survive, small palpable nodules and hemorrhagic areas appear after several weeks. Generalized infiltration of the alveolar walls with lymphocytes (ie, numerous macrophages in alveolar spaces) occurs. Bronchiolitis obliterans occurs in various stages of organization and is responsible for the palpable nodules.
Proliferative bronchiolitis is characterized by granulation tissue that primarily involves the bronchiolar lumen. It rarely involves alveolar spaces. In contrast, constrictive bronchiolitis involves collagenous scarring of the lumen with proliferation of underlying smooth and occasional luminal erosions.
[Guideline] World Health Organization. WHO Air quality guidelines for particulate matter, ozone, nitrogen dioxide and sulfur dioxide. Available at http://whqlibdoc.who.int/hq/2006/WHO_SDE_PHE_OEH_06.02_eng.pdf. Accessed: November 12, 2013.
Andersen ZJ, Kristiansen LC, Andersen KK, et al. Stroke and long-term exposure to outdoor air pollution from nitrogen dioxide: a cohort study. Stroke. 2012 Feb. 43(2):320-5. [Medline].
Chen R, Samoli E, Wong CM, Huang W, Wang Z, Chen B, et al. Associations between short-term exposure to nitrogen dioxide and mortality in 17 Chinese cities: the China Air Pollution and Health Effects Study (CAPES). Environ Int. 2012 Sep 15. 45:32-8. [Medline].
Environmental Protection Agency. Nitrogen Dioxide. Available at http://www.epa.gov/air/nitrogenoxides/health.html. Accessed: November 12, 2013.
Environmental Protection Agency. An Introduction to Indoor Air Quality (IAQ) - Nitrogen Dioxide (NO2). Available at http://www.epa.gov/iaq/no2.html. Accessed: November 12, 2013.
Stieb DM, Szyszkowicz M, Rowe BH, Leech JA. Air pollution and emergency department visits for cardiac and respiratory conditions: a multi-city time-series analysis. Environ Health. 2009 Jun 10. 8:25. [Medline]. [Full Text].
Environmental Protection Agency. National Ambient Air Quality Standards (NAAQS). Available at http://www.epa.gov/air/criteria.html. Accessed: November 12, 2013.
American Lung Association. Nitrogen Dioxide. Available at http://www.lung.org/healthy-air/outdoor/resources/nitrogen-dioxide.html. Accessed: November 12, 2013.
Environmental Protection Agency. National Trends in Nitrogen Dioxide Levels. Available at http://www.epa.gov/airtrends/nitrogen.html. Accessed: November 12, 2013.
Belanger K, Gent JF, Triche EW, Bracken MB, Leaderer BP. Association of indoor nitrogen dioxide exposure with respiratory symptoms in children with asthma. Am J Respir Crit Care Med. 2006 Feb 1. 173(3):297-303. [Medline]. [Full Text].
Lee K, Xue J, Geyh AS, Ozkaynak H, Leaderer BP, Weschler CJ, et al. Nitrous acid, nitrogen dioxide, and ozone concentrations in residential environments. Environ Health Perspect. 2002 Feb. 110(2):145-50. [Medline]. [Full Text].
van Strien RT, Gent JF, Belanger K, Triche E, Bracken MB, Leaderer BP. Exposure to NO2 and nitrous acid and respiratory symptoms in the first year of life. Epidemiology. 2004 Jul. 15(4):471-8. [Medline].
Kahan ES, Martin UJ, Spungen S, Ciccolella D, Criner GJ. Chronic cough and dyspnea in ice hockey players after an acute exposure to combustion products of a faulty ice resurfacer. Lung. 2007 Jan-Feb. 185(1):47-54. [Medline].
Centers for Disease Control and Prevention. Silo-Filler's disease in rural New York. MMWR Morb Mortal Wkly Rep. 1982 Jul 23. 31(28):389-91. [Medline].
Zwemer FL Jr, Pratt DS, May JJ. Silo filler's disease in New York State. Am Rev Respir Dis. 1992 Sep. 146(3):650-3. [Medline].
Hesterberg TW, Bunn WB, McClellan RO, Hamade AK, Long CM, Valberg PA. Critical review of the human data on short-term nitrogen dioxide (NO2) exposures: evidence for NO2 no-effect levels. Crit Rev Toxicol. 2009. 39(9):743-81. [Medline].
Kimbrough ES, Baldauf RW, Watkins N. Seasonal and diurnal analysis of NO2 concentrations from a long-duration study conducted in Las Vegas, Nevada. J Air Waste Manag Assoc. 2013 Aug. 63(8):934-42. [Medline].
Baldauf R, Thoma E, Hays M, et al. Traffic and meteorological impacts on near-road air quality: summary of methods and trends from the Raleigh Near-Road Study. J Air Waste Manag Assoc. 2008 Jul. 58(7):865-78. [Medline].
Ichinose F, Roberts JD Jr, Zapol WM. Inhaled nitric oxide: a selective pulmonary vasodilator: current uses and therapeutic potential. Circulation. 2004 Jun 29. 109(25):3106-11. [Medline].
Romieu I, Sienra-Monge JJ, Ramírez-Aguilar M, Moreno-Macías H, Reyes-Ruiz NI, Estela del Río-Navarro B, et al. Genetic polymorphism of GSTM1 and antioxidant supplementation influence lung function in relation to ozone exposure in asthmatic children in Mexico City. Thorax. 2004 Jan. 59(1):8-10. [Medline]. [Full Text].
Gilliland FD. Outdoor air pollution, genetic susceptibility, and asthma management: opportunities for intervention to reduce the burden of asthma. Pediatrics. 2009 Mar. 123 Suppl 3:S168-73. [Medline]. [Full Text].
Mushtaq N, Ezzati M, Hall L, et al. Adhesion of Streptococcus pneumoniae to human airway epithelial cells exposed to urban particulate matter. J Allergy Clin Immunol. 2011 May. 127(5):1236-42.e2. [Medline].
Neupane B, Jerrett M, Burnett RT, Marrie T, Arain A, Loeb M. Long-term exposure to ambient air pollution and risk of hospitalization with community-acquired pneumonia in older adults. Am J Respir Crit Care Med. 2010 Jan 1. 181(1):47-53. [Medline].
US Food and Drug Administration. FDA Drug Safety Communication: Serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. Available at http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. Accessed: July 27, 2011.